Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis
H Hussein, E Abbas, S Keshavarzi, R Fazelzad… - Radiology, 2023 - pubs.rsna.org
Background The best supplemental breast cancer screening modality in women at average
risk or intermediate risk for breast cancer with dense breast and negative mammogram …
risk or intermediate risk for breast cancer with dense breast and negative mammogram …
systematic review on electrochemical biosensing of breast cancer miRNAs to develop alternative DCIS diagnostic tool
S Sornambikai, H Amir, G Bhuvaneshwari… - ECS Sensors …, 2022 - iopscience.iop.org
Till date, no systematic review is conducted on electrochemical biosensing of multiplexed
breast cancer miRNAs to identify their suitability as an alternative diagnostic tool for ductal …
breast cancer miRNAs to identify their suitability as an alternative diagnostic tool for ductal …
Prediction of upstaging in ductal carcinoma in situ based on mammographic radiomic features
Background Improving diagnosis of ductal carcinoma in situ (DCIS) before surgery is
important in choosing optimal patient management strategies. However, patients may harbor …
important in choosing optimal patient management strategies. However, patients may harbor …
Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
F Galati, V Rizzo, G Moffa, C Caramanico… - European Radiology …, 2022 - Springer
Background Breast cancer (BC) includes different pathological and molecular subtypes. This
study aimed to investigate whether multiparametric magnetic resonance imaging (mpMRI) …
study aimed to investigate whether multiparametric magnetic resonance imaging (mpMRI) …
Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis
D Wekking, M Porcu, P De Silva, L Saba… - Current oncology …, 2023 - Springer
Abstract Purpose of Review This article aims to provide an updated overview of the
indications for diagnostic breast magnetic resonance imaging (MRI), discusses the available …
indications for diagnostic breast magnetic resonance imaging (MRI), discusses the available …
[HTML][HTML] Non-mass enhancement breast lesions: MRI findings and associations with malignancy
G Liu, Y Li, SL Chen, Q Chen - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
Background Magnetic resonance imaging (MRI) is a multi-sequence imaging technique.
Although MRI is the most sensitive method for detecting breast cancer, it is limited in …
Although MRI is the most sensitive method for detecting breast cancer, it is limited in …
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in …
M Kaiyin, T Lingling, T Leilei, L Wenjia, J Bin - Breast Cancer Research …, 2023 - Springer
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more
patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for …
patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for …
Artificial intelligence (AI) in breast imaging: A scientometric umbrella review
Artificial intelligence (AI), a rousing advancement disrupting a wide spectrum of applications
with remarkable betterment, has continued to gain momentum over the past decades. Within …
with remarkable betterment, has continued to gain momentum over the past decades. Within …
Ultra-high b-value diffusion-weighted imaging-based abbreviated protocols for breast cancer detection
S Ohlmeyer, FB Laun, S Bickelhaupt, T Palm… - Investigative …, 2021 - journals.lww.com
Objectives Contrast-enhanced (CE) magnetic resonance imaging (MRI) is the most effective
imaging modality for breast cancer detection. A contrast agent–free examination technique …
imaging modality for breast cancer detection. A contrast agent–free examination technique …
Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI‐Based Radiomics
M Hong, S Fan, Z Yu, C Gao, Z Fang… - Journal of Magnetic …, 2023 - Wiley Online Library
Background About 20%–40% of patients diagnosed with ductal carcinoma in situ (DCIS) by
core needle biopsy (CNB) will develop invasive cancer at the time of excision. Improving the …
core needle biopsy (CNB) will develop invasive cancer at the time of excision. Improving the …